$2.17
Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
CalciMedica Announces One-for-Five Reverse Stock Split
CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates
Overview
52-week range
$0.51
$36
5% of range
Avg surprise (last 3)
+12.6%
Avg reaction (last 2)
+2.9%
50% positive
Latest IV / EM
251%
EM ±18.1% · $1 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.45 | — | — | — | — | financials |
| Tue May 12, 2026 | Mar/2026 | $-0.22 | $-0.28 | +21.4% | +38.9% | +6.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.52 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.40 | $-0.40 | 0.0% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.36 | $-0.43 | +16.3% | — | -0.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.50 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.36 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.01 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.82 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.11 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-23.43 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-6M | — | $-6M | $-7M | $-6M | — | $-6M |
| Net income | $-8M | $5M | — | $-8M | $-6M | $-5M | — | $-6M |
| EPS (diluted) | $-0.45 | $0.30 | — | $-0.52 | $-0.40 | $-0.36 | — | $-0.50 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $19M | $8M | $12M | $5M | $6M | $13M | $8M | $9M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $19M | $9M | $14M | $15M | $19M | $25M | $20M | $16M |
| Total assets | $20M | $9M | $14M | $15M | $19M | $25M | $20M | $16M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $14M | $10M | $20M | $15M | $13M | $14M | $5M | $7M |
| Total equity | $6M | $-1M | $-7M | $-268,000 | $6M | $11M | $14M | $9M |